28 Followers USX:BMY - Bristol-Myers Squibb Co Bristol-Myers Squibb Company
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 27 Jul 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 76.19    +0.23 (+0.30%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

20 May 2022


Loading...
Loading...
Loading...

General

CEO: Dr. Giovanni Caforio M.D.

IPO: 1972-01-01

Headquarters: US

Employees: 32,200

Homepage

Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Your Holdings
Dashboard
Portfolio
Options
Other Assets

Tools
Screener
Risk Manager
Other Assets
Watchlist
Alerts
Notes
Wall
Community
Forum
Blogs
Instagram
Facebook
Shared Portfolios
Shared Screeners

Collab
Tiger Brokers x StocksCafe
Saxo Trading x StocksCafe
Kenny REIT Screener

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
IG    FB    YouTube

About · FAQs · StocksCafe © 2022 · Privacy · Terms